不同年龄组倾向匹配患者行孤立机械瓣与生物瓣二尖瓣置换的长期结局
这项回顾性多中心倾向匹配观察研究纳入2000至2017年1536例孤立二尖瓣置换(806例机械瓣,730例生物瓣),比较不同年龄组长期结局。匹配患者<65岁机械瓣10年生存(78.2% vs 69.8%,P=0.029)和无再干预(96.2% vs 81.3%,P<0.001)优于生物瓣;65-75岁两组10年生存(64.6% vs 60.8%,P=0.86)和无再干预(94.0% vs 97.2%,P=0.23)无差异。
要点
- 匹配患者<65岁机械瓣10年生存和无再干预优于生物瓣。
- 匹配患者65-75岁机械瓣与生物瓣10年生存和无再干预无差异。
- 术后卒中、消化道出血、肾衰竭和永久起搏器植入率相似。
核心结论
- 在需要孤立二尖瓣置换的患者中,<65岁患者机械瓣较生物瓣显著改善长期生存和无再干预,65-75岁患者未见较生物瓣的获益。
研究设计与样本
- 回顾性、多中心、倾向匹配观察性研究,2000至2017年共行1536例孤立二尖瓣置换(806例机械瓣,730例生物瓣),超过90%的合格患者成功完成倾向匹配,<65岁组机械瓣与生物瓣各226例,65-75岁组生物瓣与机械瓣各171例,中位随访13年(最长20年)。
主要发现
- 匹配患者<65岁,机械瓣10年生存78.2% vs 生物瓣69.8%(P=0.029)。
- 匹配患者<65岁,机械瓣10年无再干预96.2% vs 生物瓣81.3%(P<0.001)。
- 匹配患者65-75岁,机械瓣与生物瓣10年生存64.6% vs 60.8%(P=0.86)。
- 匹配患者65-75岁,机械瓣与生物瓣10年无再干预94.0% vs 97.2%(P=0.23)。
- 术后卒中、消化道出血、肾衰竭和永久起搏器植入率相似。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Prothesis choice in isolated mitral valve replacement for patients aged 75 years or younger remains debated as most studies comparing prothesis type have included large proportions of combined operations and benefits are influenced by concomitant procedures. This study compared long-term outcomes of isolated mechanical versus bioprosthetic mitral valves in different age groups of propensity-matched populations. METHODS: This is a retrospective, multicentre, propensity-matched observational study. Baseline characteristics, operative details and long-term outcomes (mortality and freedom from surgical/transcatheter reintervention) were collected. RESULTS: Totally, 1536 isolated mitral valve replacements (806 mechanical, 730 bioprosthetic) were performed between 2000 and 2017. Over 90% of eligible patients successfully underwent propensity matching, yielding 226 each of mechanical and bioprosthetic valves in patients aged <65 years and 171 each of bioprosthetic and mechanical valves in patients aged 65-75 years with median follow-up of 13 years (maximum 20 years). In matched patients <65 years, 10-year survival was superior with mechanical valves versus bioprosthetic valves (78.2% vs 69.8%, P = 0.029), as was 10-year freedom from reintervention (96.2% vs 81.3%, P < 0.001). For matched patients between 65 and 75 years, there were no differences between mechanical and bioprosthetic valves in 10-year survival (64.6% vs 60.8%, P = 0.86) or 10-year freedom from reintervention (94.0% vs 97.2%, P = 0.23). Rates of post-operative stroke, gastrointestinal bleeding, renal failure and permanent pacemaker insertion were similar. CONCLUSIONS: In patients requiring isolated mitral valve replacement, mechanical valves confer significantly better long-term survival and freedom from reintervention for patients <65 years, while no benefit is observed at age 65-75 years compared to bioprosthetic valves.
引用
- Rokui S, Gottschalk B, Peng D, et al. Long-term outcomes of isolated mechanical versus bioprosthetic mitral valve replacement in different age groups of propensity-matched patients. Eur J Cardiothorac Surg. 2024. PMID: 38936344. doi:10.1093/ejcts/ezae245
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。